Lux Capital is a New York-based venture capital firm founded in 2000 by Josh Wolfe and Peter Hébert. The firm focuses on what it calls "the edges of science and technology" – deep tech, defense, artificial intelligence, biotechnology, materials science, and space. It operates from offices in New York and Menlo Park, California, and manages more than $4 billion in assets across multiple funds. Its eighth flagship fund, closed in 2022, raised approximately $1.15 billion.
Lux Capital is not a crypto-native investor. Its participation in the digital asset space is selective and typically tied to companies at the intersection of frontier science and decentralized infrastructure – molecular computing, AI-driven trading systems, or cryptography-heavy security tools. With 11 tracked crypto and blockchain-adjacent portfolio investments and a single recorded lead, Lux treats this sector as a peripheral allocation rather than a core thesis. The firm has been openly skeptical of speculative token markets while remaining interested in foundational cryptographic primitives and privacy-preserving computation.
Notable investments
Lux Capital's broader portfolio includes some of the most high-profile deep tech companies of the past decade. In the crypto and adjacent space its holdings are narrower, but the firm has backed companies working on secure computation and AI infrastructure that overlap with blockchain use cases. Its wider portfolio highlights include:
- Joby Aviation – electric vertical takeoff and landing vehicles; went public via SPAC in 2021
- Commonwealth Fusion Systems – nuclear fusion startup backed alongside Google and Breakthrough Energy
- Shield AI – autonomous defense AI; valued at over $2.7 billion as of 2023
- Kymera Therapeutics – protein degradation biotech; IPO in 2020
- Seer Bio – proteomics platform; IPO in 2020
- Osmo – AI-based smell digitization, spun out of Google in 2023 with Lux leading the seed round
- Anduril Industries – defense technology; co-investor alongside other top-tier funds
Public information about specific crypto portfolio companies held by Lux Capital is limited. The firm does not regularly publicize token investments or blockchain-native deals, and its crypto-adjacent positions tend to be in equity rounds of infrastructure or privacy companies rather than direct token purchases.
Team
Josh Wolfe is co-founder and managing partner. He is among the most recognizable figures in deep tech venture, frequently quoted in media on technology, national security, and the future of science. He co-authors the firm's widely read annual letter and is active on social media discussing macro trends. Peter Hébert is co-founder and managing partner, responsible for much of the firm's operational and investment strategy. The broader partnership includes Bilal Zuberi, Grace Isford, and several other principals who lead sector-specific deal flow across biotech, defense, and computing.
Recent activity
Between 2024 and early 2026, Lux Capital concentrated new capital on artificial intelligence infrastructure, national security technology, and biological computation. The firm participated in rounds for companies developing large-scale AI training hardware and autonomous defense systems. It has been vocal about the United States needing to lead in frontier technology relative to geopolitical rivals, a theme that shapes its deal selection.
On the crypto side, activity has been quiet. No major crypto-native lead investments have been publicly reported in the past 18 months. The firm's posture appears to remain one of cautious observation – interested in cryptographic security and zero-knowledge proof applications, but not actively deploying into speculative token ecosystems.
Lux Capital's long-term outlook is tied to deep science rather than financial engineering. For crypto investors tracking this fund, its value signal lies in its peripheral bets on privacy infrastructure and secure computation rather than direct market exposure. More information is available on the Lux Capital official site and its Crunchbase profile.